PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 2111513
PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 2111513
Elastography Imaging market size was valued at US$ 5,001.3 Million in 2025, expanding at a CAGR of 6.1% from 2026 to 2033.
The elastography imaging technique is a non-invasive imaging technology that makes use of quantitative evaluation of tissue stiffness or strain of an organ using ultrasound or magnetic resonance (MR) imaging in order to generate quantitative biomarker maps for the diagnosis of fibrosis, inflammatory conditions, and tumors. The main components of the elastography system consist of: Mechanical stimulation transducer (ultrasound acoustic radiation force, external vibration, and manual compression); high frame rate displacement tracking techniques (either ultrasound or MR tracking); and finally, signal processing technique for converting the displacement information into a color-coded elasticity map superimposed on the anatomical image. This provides visual representation of the elasticity data for better visualization of elastic properties of tissues and disease diagnosis.
Elastography Imaging Market- Market Dynamics
Increasing Cases of Chronic Liver Disease and Breast Cancer to Boost Market Expansion
The increasing prevalence of chronic liver disease and breast cancer makes it necessary to use elastography imaging, as an increasing number of specialists employ this modern technique to diagnose and evaluate the condition of the tissue and treatment of the diseases. In October 2025, as stated by the Liver Cancer UK Org, new data published by the Office for National Statistics (ONS) showed that the number of liver cancer deaths in England and Wales increased by 41 percent and rose 23 times due to aging of the population and more frequent detection of liver cancer cases and mortality rate from liver cancer annually, with about 6,000 liver cancer cases annually in the UK (about 17 liver cancer cases per day). Less than 13 percent of patients with liver cancer are still alive five years after diagnosis, and only 8 percent live 10 years after treatment. These rising disease rates are expected to accelerate the adoption of elastography imaging worldwide.
The Global Elastography Imaging market is segmented on the basis of Modality, Application, End Use, and Region.
Based on modality, ultrasound holds a prominent share in the elastography imaging market. It is commonly utilized in the non-invasive investigation of tissue stiffness, real-time elasticity imaging, and accurate diagnosis of liver fibrosis, breast cancer, thyroid disease, and musculoskeletal disorders in hospitals, clinics, and medical research institutions. For example, in March 2025, according to the Society of Radiographers (Org), increasing shortages in the number of sonographers have already influenced the demand for ultrasound services as a whole, when the number of sonography vacancies has reached 24.2% (United Kingdom). The 2025 census revealed the results based on 161 respondents out of 142 ultrasound service providers, of whom 153 have taken part in the survey. Of the vacancies, 25.3% are found in the NHS and only 11.6% in the independent sector. Thus, the widespread adoption and expanding clinical applications of ultrasound continue to strengthen its market dominance.
The hepatology segment holds a notable share in the global Elastography Imaging market because of the non-invasive measurement of liver stiffness using the elastography technique, which helps to make early diagnoses of liver fibrosis and facilitate diagnoses and monitoring of chronic liver diseases like hepatitis and cirrhosis. In June 2025, according to ISGlobal.org, there have been more than 1.5 billion cases of chronic liver diseases worldwide; however, they are not included in the global NCD policies. Further, metabolic dysfunction-associated steatotic liver disease (MASLD) accounts for one-third (33%) of the global adult population. These trends are expected to accelerate elastography adoption across hepatology diagnostics and disease management.
Elastography Imaging Market- Geographical Insights
North America accounts for a substantial share of the Elastography Imaging market because of the involvement of key players in the industry along with constant efforts towards commercialization of the market. In June 2026, according to the Government of Canada, Canada is stepping up its engagement on bilateral and economic dimensions of the India trade story with a new trade diversification strategy, with the goal of doubling two-way trade with India to USD 50,400 million/year by 2030. According to the report, Two-way merchandise trade between the two countries was estimated at USD 7,848 million in 2025. Canadian exports jumped 32% to USD 2,808 million (approximately CAD 3.9 billion), while the Indian exports were USD 5,040 million Meanwhile, service exports from Canada were USD 11,232 million. These continued efforts for commercialization have resulted in making the North American region a dominant player in the elastography imaging market.
Some of the major players in the elastography imaging industry, such as Canon Medical Systems Corporation, GE HealthCare, Koninklijke Philips N.V., Samsung Medison Co., Ltd., and Esaote SpA, are growing their market footprint through investments in product development, R&D activities, and the latest ultrasound imaging technology. In February 2026, GE HealthCare launched their new generation LOGIQ ultrasound system, which is capable of advanced liver imaging, smart automation technology, smart workflow technology, and next-generation ultrasound imaging techniques for advanced elastography-based tissue characteristics and diagnostics. These strategic advancements are expected to accelerate market growth by improving diagnostic accuracy and clinical adoption globally.
In November 2025, Samsung Medison Co., Ltd. launched the R20 ultrasound machine during RSNA 2025, featuring the use of artificial intelligence (AI)-enabled automation, the latest imaging technology, and state-of-the-art ultrasound technology that includes improved tissue characterisation and elastography application.